Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Drugs

Epoetin alfa Product Approval Information - Licensing Action 7/26/99

Proper name: Epoetin alfa
Tradename: Epogen, Procrit
Manufacturer: Amgen, Inc, Thousand Oaks, CA, License #1080
Indication for Use: Pediatric Use
Approval Date: 7/26/99
Type of submission: Biologics license supplement

 


Approval Letter (PDF)

Label (PDF)

Reviews
     Medical Review
     Statistical Review
     Clinical Pharmacology Review: Pharmacokinetics

Adverse Events List (PDF)

Page Last Updated: 09/30/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English